Stay in touch

You are here

Blog

It’s up to the IRS to ensure that nonprofits are not being used as illicit vehicles to funnel untraceable money into our elections. Unfortunately, the agency’s handling of this responsibility has been thoroughly outrageous, the latest scandal being just the latest example of disturbing action—or, as has been more often the case, inaction.

Everyone knows prescription drugs cost much more than they should. But many people are surprised to learn about one of the key ways drug companies keep prices high: Paying off competitors to keep generics off the market. On Monday, the Supreme Court heard arguments in a case about this very practice.